Articles & Issues

Alert me when new Articles in Press are available. Add Articles in Press Alert   Request Articles in Press Alert via email or RSS Feed   Request RSS feed of Articles in Press

10 Articles

  • 1
Article Title Author(s) Type (Status) Available Online
Changes Associated With Lenalidomide Treatment in the Gene Expression Profiles of Patients With Del(5q)

DOI: 10.1016/j.clml.2012.04.003

Monika Belickova, Jaroslav Cermak, Michaela Dostalova Merkerova, Jitka Vesela, Zdenek Krejcik, Eliska Cechova, Zuzana Zemanova, Kyra Michalova, Hana Votavova, Miroslav Caniga, Radana Neuwirtova, Anna Jonasova et al. Full-length article
(In Press Corrected Proof)
21 May 2012
Clinical Cytogenetics in Pediatric Acute Leukemia: An Update

DOI: 10.1016/j.clml.2012.04.004

Maria Braoudaki, Fotini Tzortzatou-Stathopoulou Review article
(In Press Corrected Proof)
21 May 2012
A Phase II Study of Lenalidomide Alone in Relapsed/Refractory Acute Myeloid Leukemia or High-Risk Myelodysplastic Syndromes With Chromosome 5 Abnormalities

DOI: 10.1016/j.clml.2012.04.001

Yiming Chen, Hagop Kantarjian, Zeev Estrov, Stefan Faderl, Farhad Ravandi, Kristy Rey, Jorge Cortes, Gautam Borthakur et al. Full-length article
(In Press Corrected Proof)
14 May 2012
Mutational Status and Gene Repertoire of IGHV-IGHD-IGHJ Rearrangements in Serbian Patients With Chronic Lymphocytic Leukemia

DOI: 10.1016/j.clml.2012.03.005

Teodora Karan-Djurasevic, Vuk Palibrk, Tatjana Kostic, Vesna Spasovski, Gordana Nikcevic, Sanja Srzentic, Milica Colovic, Natasa Colovic, Ana Vidovic, Darko Antic, Biljana Mihaljevic, Sonja Pavlovic, Natasa Tosic et al. Full-length article
(In Press Corrected Proof)
07 May 2012
Clinical Binding Properties, Internalization Kinetics, and Clinicopathologic Activity of Brentuximab Vedotin: An Antibody-Drug Conjugate for CD30-Positive Lymphoid Neoplasms

DOI: 10.1016/j.clml.2012.01.012

Jonathan R. Fromm, Julie A. McEarchern, Dana Kennedy, Anju Thomas, Andrei R. Shustov, Ajay K. Gopal et al. Short communication
(In Press Corrected Proof)
27 April 2012
Pralatrexate Is an Effective Treatment for Relapsed or Refractory Transformed Mycosis Fungoides: A Subgroup Efficacy Analysis From the PROPEL Study

DOI: 10.1016/j.clml.2012.01.010

Francine Foss, Steven M. Horwitz, Bertrand Coiffier, Nancy Bartlett, Leslie Popplewell, Barbara Pro, Lauren C. Pinter-Brown, Andrei Shustov, Richard R. Furman, Corinne Haioun, Tony Koutsoukos, Owen A. O'Connor et al. Full-length article
(In Press Corrected Proof)
27 April 2012
Twice-Daily Fludarabine and Cytarabine Combination With or Without Gentuzumab Ozogamicin is Effective in Patients With Relapsed/Refractory Acute Myeloid Leukemia, High-Risk Myelodysplastic Syndrome, and Blast- Phase Chronic Myeloid Leukemia

DOI: 10.1016/j.clml.2012.03.003

Elias Jabbour, Guillermo Garcia-Manero, Jorge Cortes, Farhad Ravandi, William Plunkett, Varsha Gandhi, Stefan Faderl, Susan O'Brien, Gautam Borthakur, Tapan Kadia, Jan Burger, Marina Konopleva, Mark Brandt, Xuelin Huang, Hagop Kantarjian et al. Full-length article
(In Press Corrected Proof)
26 April 2012
The Effects of Increased Expression of DLK1 Gene on the Pathogenesis of Myelodysplastic Syndromes

DOI: 10.1016/j.clml.2012.03.002

Xiaotang Ma, Yue Zhang, Lin Yang, Zefeng Xu, Zhijian Xiao et al. Full-length article
(In Press Corrected Proof)
19 April 2012
Detection of CD34, TdT, CD56, CD2, CD4, and CD14 by Flow Cytometry Is Associated With NPM1 and FLT3 Mutation Status in Cytogenetically Normal Acute Myeloid Leukemia

DOI: 10.1016/j.clml.2012.01.003

Bakul I. Dalal, Soudeh Mansoor, Mita Manna, Steven Pi, Giovanna Di Sauro, Donna E. Hogge et al. Full-length article
(In Press Corrected Proof)
05 April 2012
Does an Elevated Serum Vitamin B12 Level Mask Actual Vitamin B12 Deficiency in Myeloproliferative Disorders?

DOI: 10.1016/j.clml.2012.01.008

Dron Gauchan, Nitin Joshi, Amandeep Singh Gill, Vishal Patel, Vincent A. DeBari, Gunwant Guron, Michael Maroules et al. Full-length article
(In Press Corrected Proof)
19 March 2012
  • 1


Note to users: The section "Articles in Press" contains peer reviewed and accepted articles to be published in this journal. When the final article is assigned to an issue of the journal, the "Article in Press" version will be removed from this section and will appear in the associated journal issue. Please be aware that "Articles in Press" do not have all bibliographic details available yet. There are three types of "Articles in Press":
  • Accepted Manuscripts: these are manuscripts that have been selected for publication. They have not been typeset and the text may change before final publication.
  • Uncorrected proofs: these are articles that are not yet finalized and that will be corrected by the authors. Therefore the text could change before final publication. Uncorrected proofs may be temporarily unavailable for production reasons.
  • Corrected proofs: these are articles containing the authors' corrections. The content of the article will usually remain unchanged, and possible further corrections are fairly minor. Typically the only difference with the finally published article is that specific issue and page numbers have not yet been assigned.